Abstract
Venous thromboembolism (VTE) persists in hospitalized patients in spite of well-recognized risk factors. VTE includes deep vein thrombosis (DVT) as well as pulmonary embolism (PE). Virchow’s triad explains the pathophysiology underlying VTE, and is comprised of venous stasis, endothelial injury, and hypercoagulability. In the lower extremity, because signs and symptoms (swelling, pain, and discoloration) remain subtle or occult in up to 50% of patients, a high index of clinician suspicion is required to minimize undiagnosed cases. The Caprini score is an excellent tool to assist in VTE risk stratification and can help guide prophylaxis with low molecular weight heparin and sequential compression devices. Duplex ultrasound is the initial diagnostic test of choice. In the upper extremity, DVT is often iatrogenic and secondary to indwelling devices, such as central venous catheters or pacemaker leads. Pulmonary embolism occurs in up to 40% of DVT. Untreated, the mortality of PE is at least 25%. Long-term sequelae of VTE include postphlebitic syndrome and pulmonary hypertension. Initial treatment of VTE consists of systemic anticoagulation. Percutaneous interventions are reserved for severe cases of iliofemoral DVT or massive PE.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dobromirski M, Cohen AT. How I manage venous thromboembolism risk in hospitalized medical patients. Blood. 2012;120(8):1562–9. https://doi.org/10.1182/blood-2012-03-378901.
Cohen AT, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE Study): a multinational cross-sectional study. Lancet. 2008;371(9610):387–94. https://doi.org/10.1016/s0140-6736(08)60202-0.
Muñoz FJ, et al. Clinical outcome of patients with upper-extremity deep vein thrombosis. Chest. 2008;133(1):143–8. https://doi.org/10.1378/chest.07-1432.
Douketis JD, et al. Deep venous thrombosis (DVT) – cardiovascular disorders. Merck Manuals Professional Edition. Merck Manuals; 2021.
Kahn SR. The post-thrombotic syndrome. Hematology. 2016;2016(1):413–8. https://doi.org/10.1182/asheducation-2016.1.413.
Prandoni P, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. J Vasc Surg. 2005;41(1):177. https://doi.org/10.1016/j.jvs.2004.10.021.
Amaragiri, Sachiendra V, and Timothy Lees. “Elastic compression stockings for prevention of deep vein thrombosis.” Cochrane Database Syst Rev, 2000 (3):CD001484, doi:https://doi.org/10.1002/14651858.cd001484.
Roderick P, et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess. 2005;9(49):iii–iv, ix–x, 1–78. https://doi.org/10.3310/hta9490.
Vanek VW. Meta-analysis of effectiveness of intermittent pneumatic compression devices with a comparison of thigh-high to knee-high sleeves. Am Surg. 1998;64(11):1050–8. https://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?AccessionNumber=11998001884&AccessionNumber=11998001884. Accessed 6 Oct 2019.
Laporte-Simitsidis S, et al. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost. 2000;83(01):14–9. https://doi.org/10.1055/s-0037-1613749.
Watson L, et al. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev. 2016;11(11):CD002783. https://doi.org/10.1002/14651858.cd002783.pub4.
Vedantham S, et al. Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol. 2014;25(9):1317–25. https://doi.org/10.1016/j.jvir.2014.04.019.
White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I4–8. https://doi.org/10.1161/01.cir.0000078468.11849.66.
Moheimani F, Jackson DE. Venous thromboembolism: classification, risk factors, diagnosis, and management. ISRN Hematol. 2011;2011:1–7. https://doi.org/10.5402/2011/124610.
Anderson FA, Wheeler HB. Physician practices in the management of venous thromboembolism: a community-wide survey. J Vasc Surg. 1992;16(5):707–14. https://doi.org/10.1016/0741-5214(92)90225-w.
Anderson FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I9–16. https://doi.org/10.1161/01.cir.0000078469.07362.e6.
Ho WK, et al. Risk of recurrent venous thromboembolism in patients with common thrombophilia. Arch Intern Med. 2006;166(7):729. https://doi.org/10.1001/archinte.166.7.729.
Tapson VF. The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(1):71–7. https://doi.org/10.1513/pats.200407-038ms.
Feher MD, et al. Acute changes in atherogenic and thrombogenic factors with cessation of smoking. J R Soc Med. 1990;83(3):146–8. https://doi.org/10.1177/014107689008300306.
Comerota AJ, et al. Endovascular thrombus removal for acute iliofemoral deep vein thrombosis. Circulation. 2019;139(9):1162–73. https://doi.org/10.1161/circulationaha.118.037425.
Doleman B, et al. Phlegmasia caerulea dolens secondary to pelvic plasmacytoma and left femoral deep vein thrombosis. Int J Surg Case Rep. 2013;4(10):825–7. https://doi.org/10.1016/j.ijscr.2013.07.010.
Kahn SR, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. J Vasc Surg. 2009;49(5):1358. https://doi.org/10.1016/j.jvs.2009.03.021.
Farrell JJ, et al. Incidence and interventions for post-thrombotic syndrome. Cardiovasc Diagn Ther. 2016;6(6):623–31. https://doi.org/10.21037/cdt.2016.11.22.
Kearon C. Natural history of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I22–30. https://doi.org/10.1161/01.cir.0000078464.82671.78.
Min S-K, et al. Diagnosis and treatment of lower extremity deep vein thrombosis: Korean practice guidelines. Vasc Specialist Int. 2016;32(3):77–104. https://doi.org/10.5758/vsi.2016.32.3.77.
Casey ET, et al. Treatment of acute iliofemoral deep vein thrombosis. J Vasc Surg. 2012;55(5):1463–73. https://doi.org/10.1016/j.jvs.2011.12.082.
Bĕlohlávek J, et al. Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013;18(2):129–38.
Horlander KT, et al. Pulmonary embolism mortality in the United States, 1979–1998. Arch Intern Med. 2003;163(14):1711. https://doi.org/10.1001/archinte.163.14.1711.
Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med. 2004;164(1):17. https://doi.org/10.1001/archinte.164.1.17.
Mumoli N, et al. Phlegmasia cerulea dolens. Circulation. 2012;125(8):1056–7. https://doi.org/10.1161/circulationaha.111.051912.
Kropp AT, et al. The efficacy of forceful ankle and toe exercises to increase venous return: a comprehensive doppler ultrasound study. Phlebology. 2017;33(5):330–7. https://doi.org/10.1177/0268355517706042.
Bose E, Hravnak M. Thromboelastography: a practice summary for nurse practitioners treating hemorrhage. J Nurse Pract. 2015;11(7):702–9. https://doi.org/10.1016/j.nurpra.2015.05.006.
Chaochankit W, Akaraborworn O. Phlegmasia cerulea dolens with compartment syndrome. Ann Vasc Dis. 2018;11(3):355–7. https://doi.org/10.3400/avd.cr.18-00030.
Goodacre S, et al. Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Med Imaging. 2005;5(1):6. https://doi.org/10.1186/1471-2342-5-6.
Nicolas D, Nicolas S, Reed M. Heparin induced thrombocytopenia (HIT) [updated 2020 Feb 14]. In: StatPearls [internet]. Treasure Island (FL): StatPearls Publishing; 2020.
Morrison H. Catheter-directed thrombolysis for acute limb ischemia. Semin Interv Radiol. 2006;23(3):258–69. https://doi.org/10.1055/s-2006-948765.
Kearon C, et al. Antithrombotic therapy for VTE disease. Chest. 2012;141(2):E419S–96S. https://doi.org/10.1378/chest.11-2301.
Chung J, et al. Pilot study evaluating the efficacy of exergaming for the prevention of deep venous thrombosis. J Vasc Surg. 2017;66(3):e55–6. https://doi.org/10.1016/j.jvs.2017.05.071.
Van Der Heijden JF, et al. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev. 2001;4:CD002001. https://doi.org/10.1002/14651858.cd002001.
Neglén P, et al. Endovascular surgery in the treatment of chronic primary and post-thrombotic iliac vein obstruction. Eur J Vasc Endovasc Surg. 2000;20(6):560–71. https://doi.org/10.1053/ejvs.2000.1251.
Srinivas BC, et al. Outcome of venous stenting following catheter directed thrombolysis for acute proximal lower limb venous thrombosis: a prospective study with venous doppler follow-up at 1-year. Cardiovasc Interv Ther. 2015;30(4):320–6. https://doi.org/10.1007/s12928-015-0317-5.
Vedantham S, et al. Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):68–80. https://doi.org/10.1007/s11239-015-1318-z.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hudefi, N., Chung, J. (2022). Perioperative Venous Thromboembolism. In: Gilani, R., Mills Sr., J.L. (eds) Vascular Complications of Surgery and Intervention. Springer, Cham. https://doi.org/10.1007/978-3-030-86713-3_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-86713-3_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-86712-6
Online ISBN: 978-3-030-86713-3
eBook Packages: MedicineMedicine (R0)